The purpose of this study was to assess the independent effect of increased body size on left ventricular (LV) diastolic function.
The prevalence of obesity is steadily increasing worldwide, and constitutes a major health issue because of its association with morbidity, mortality, and cardiovascular diseases (1) (2) (3) . Obesity is an independent predictor of incident heart failure in the general population, and evidence exists that overweight also carries an increased risk of heart failure, which is intermediate between that of obese and lean persons (4, 5) . An increase in body size, besides being associated with cardiovascular risk factors such as hypertension, diabetes mellitus, and hyperlipidemia, directly affects cardiac structure and function. The excess in body fat determines an increase in both pre-load and afterload due to a hyperdynamic circulation, chronic volume overload, and increase in peripheral resistance (6, 7) . In addition, it has been demonstrated that increased adiposity enhances the effect of blood pressure on left ventricular (LV) mass growth (8) . As a result, LV dilation and increased LV mass are frequent findings in persons with increased body weight, with both eccentric and concentric LV geometric patterns described in these conditions (9 -11) .
Left ventricular diastolic dysfunction is a condition that reflects an impairment of the filling properties of the left ventricle that has been demonstrated to be a predictor of future development of heart failure in population settings (12) (13) (14) (15) . Left ventricular diastolic dysfunction might, therefore, represent one of the pathophysiological links between an increased body weight and the future occurrence of heart failure. Cardiovascular risk factors and cardiac structural changes associated with obesity/overweight are also major determinants of LV diastolic function (16, 17) . Whether an increased body weight is associated with an impairment of LV diastolic mechanics, independent of associated risk factors, has not been fully established. Accordingly, the aims of our study were: 1) to analyze the association between body size and LV diastolic function, assessed by transthoracic echocardiography, in a community-based cohort of subjects over age 50 years; 2) to evaluate the impact of associated risk factors on this relationship; and 3) to investigate the effect of different degrees of increased body size on the risk of LV diastolic dysfunction.
Methods
Study population. The study cohort was derived from the NOMAS (Northern Manhattan Study), a population-based prospective study evaluating the incidence, risk factors, and clinical outcome of stroke in the population of northern Manhattan. Study design and methodological details have been described previously (18) . From September 2005, the NOMAS subjects Ͼ50 years of age who voluntarily agreed to undergo a brain magnetic resonance imaging study and a more extensive echocardiographic evaluation including diastolic function assessment were included in the CABL (Cardiac Abnormalities and Brain Lesion) study. This subset of subjects constitutes the study population of the present report. Informed consent was obtained from all study participants. The study was approved by the institutional review board of Columbia University Medical Center. Risk factors assessment. Hypertension was defined as systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg at the time of the visit (mean of 2 readings), or the patient's self-reported history of hypertension or use of antihypertensive medications. Diabetes mellitus was defined as fasting blood glucose Ն126 mg/dl or the patient's self-reported history of diabetes or use of diabetes medications. Hypercholesterolemia was defined as total serum cholesterol Ͼ240 mg/dl, and the patient's self-report of hypercholesterolemia or use of lipidlowering treatment. Body mass index (BMI) was calculated as weight (kg) divided by height-squared (m 2 ). According to a standard definition, overweight was defined as BMI between 25.0 and 29.9 kg/m 2 , and obesity as BMI Ն30 kg/m 2 (19) . Echocardiographic assessment. Transthoracic echocardiography was performed using a commercially available system (iE 33, Philips, Andover, Massachusetts) by a trained registered sonographer following a standardized protocol. The LV linear dimensions were measured from a parasternal long-axis view according to the recommendations of the American Society of Echocardiography (20) . The LV mass was calculated with a validated formula (21) and indexed both for body surface area (BSA) and height 2.7 (22) . The LV relative wall thickness was calculated as follows: (2 ϫ posterior wall thickness) divided by end-diastolic diameter (23) . The LV ejection fraction was calculated by biplane modified Simpson's rule.
Left ventricular diastolic function assessment has been described previously in detail (17) . Briefly, from an apical 4-chamber view, transmitral flow was sampled by pulsedwave Doppler at the level of mitral valve leaflet tips. Peak velocities of the early phase (E) and late phase (A) of the mitral inflow were measured, and their ratio (E/A) was calculated. Left ventricular myocardial velocities were evaluated by tissue Doppler imaging (TDI). Pulsed TDI sample volume was placed at the level of the lateral and septal mitral valve annulus, and the peak early diastolic velocities (E=) were measured and then averaged (24) . The ratio between E and E= (E/E=) was calculated as an index of LV filling pressures (25) . Diastolic dysfunction was defined as 1) E/A Յ0.7 (impaired relaxation, grade I); or 2) E/A Ͼ0.7 and Յ1.5 and E= Ͻ7 cm/s (pseudonormalized pattern, grade II); or 3) E/A Ͼ1.5 and E= Ͻ7 cm/s (restrictive pattern, grade III) (17, 24) . Statistical analysis. Data are presented as mean Ϯ SD for continuous variables and as proportions for categorical variables. Differences between groups were assessed by 1-way analysis of variance and post-hoc multiple comparisons were performed using the Bonferroni correction. The Fisher's exact test was used to test differences between proportions. Multiple linear regressions were used to assess the independent association of BMI with diastolic function parameters. The predictors and the outcome variables were standardized with corresponding standard deviations and both nonstandardized (B) and standardized (␤) coefficient estimates and relative standard errors were reported. Covariates (age, sex, LV mass/height 2.7 , heart rate, hypertension, and diabetes) were entered in the models in a stepwise fashion, with entry and removal criteria set at a p Ͻ 0.1. Analysis of covariance was conducted to assess differences in diastolic function parameters between groups after adjusting for covariates. Estimated marginal means adjusted for covariates and 95% confidence intervals (CIs) were derived. Multivariate logistic models were used to assess the risk of diastolic dysfunction associated with body size measures, and odds ratios (ORs) and relative 95% CI were derived.
For all statistical analyses, a 2-tailed p Ͻ 0.05 was considered significant. Statistical analyses were performed using SPSS software version 17.0 (SPSS, Inc., Chicago, Illinois). Russo et al. March 22, 2011 March 22, :1368 Obesity, Overweight, and LV Diastolic Function
Results
Study population. The study population consisted of 950 participants. The study sample was divided into 3 groups: subjects with a BMI Ͻ25.0 kg/m 2 (normal weight group, n ϭ 242), subjects with a BMI between 25.0 and 29.9 kg/m 2 (overweight group, n ϭ 403), and subjects with a BMI Ն30 kg/m 2 (obese group, n ϭ 305). Demographic, clinical, and echocardiographic characteristics of the 3 groups are shown in Table 1 . BMI, LV mass, and cardiovascular risk factors. Since obese and overweight participants showed higher LV mass when indexed by height 2.7 , but also greater prevalence of cardiovascular risk factors, which may in turn be responsible for an increased LV mass and worse diastolic function, we explored the independent association of BMI and cardiovascular risk factors with LV mass. A higher BMI was the strongest independent predictor of increased LV mass/ height 2.7 (␤ ϭ 0.28, p Ͻ 0.001). Other independent predictors in the model were age (␤ ϭ 0.15, p Ͻ 0.001), hypertension (␤ ϭ 0.17, p Ͻ 0.001), and diabetes (␤ ϭ 0.07, p ϭ 0.02). Sex was not associated with LV mass index after adjustment for BMI (␤ ϭ Ϫ0.03, p ϭ 0.23). When LV mass was indexed by BSA instead of height 2.7 , no significant residual association was found between BMI and LV mass (␤ ϭ 0.008, p ϭ 0.81). BMI and diastolic function parameters. The correlation between BMI and echocardiographic diastolic function parameters was tested in stepwise multivariate linear regression models (Table 2 ). Higher BMI was associated with higher peak E-wave (R 2 ϭ 0.05; p ϭ 0.006), higher peak A-wave (R 2 ϭ 0.22; p Ͻ 0.001), lower E/A (R 2 ϭ 0.08; p ϭ 0.01), and higher E/E= ratio (R 2 ϭ 0.20; p ϭ 0.001), independent of factors influencing LV diastolic function including age, sex, LV mass, hypertension, diabetes, and heart rate.
In separate subanalyses by sex adjusted for age and LV mass index, we found that among men, BMI was significantly correlated with higher A (␤ ϭ 0.14, p ϭ 0.01), lower E/A (␤ ϭ Ϫ0.12, p ϭ 0.03), and lower E= (␤ ϭ Ϫ0.12, p ϭ 0.02). Among women, BMI was significantly correlated with higher E (␤ ϭ 0.15, p Ͻ 0.001), higher A (␤ ϭ 0.17, p Ͻ 0.001), and higher E/E= (␤ ϭ 0.12, p ϭ 0.003).
In a subanalysis of subjects without hypertension and diabetes (n ϭ 223), the relation between BMI and E/E= ratio was still significant (␤ ϭ 0.13, p ϭ 0.04) independent of age, LV mass index, and heart rate (variables that were selected in the stepwise model; data not shown). LV diastolic function in overweight and obesity. In multivariate comparisons (Table 3) , peak E was significantly higher in obese subjects than in normal weight subjects (p Ͻ 0.01). Peak A was significantly higher in the overweight group and the obese group (both p Ͻ 0.01) compared with the normal weight group. The E/A ratio was significantly lower in obese patients compared with normal weight subjects (p Ͻ 0.01). Peak E= was significantly lower in overweight subjects and obese subjects compared with normal weight persons (both p Ͻ 0.01). The E/E= ratio was significantly higher in overweight subjects and obese subjects compared with normal weight persons (both p Ͻ 0.01).
Prevalence of LV diastolic dysfunction in the overall sample was 53.5% (n ϭ 508). Diastolic dysfunction was present in 50.8% of the normal weight group, in 54.2% of Characteristics of the Study Population by BMI Categories 
Discussion
We analyzed the association between measures of body size and LV diastolic function, measured by traditional Doppler analysis of mitral inflow and TDI-derived parameters, in an elderly, randomly derived community cohort. Our findings indicate that: 1) the relationship between BMI and diastolic function parameters is continuous and independent of cardiovascular risk factors that cluster with obesity, such as hypertension, diabetes, and LV hypertrophy; and 2) the overweight status is already associated with an impairment of LV diastolic function, close to that observed in obese persons. In fact, no significant differences were found in most parameters of diastolic function between obese and overweight subjects. This observation was also confirmed by the similar OR for diastolic dysfunction associated with both conditions. Overweight and obese subjects had also higher risk of a pseudonormalized diastolic pattern. The use of TDI param- Abbreviations as in Table 1 .
Russo et al. March 22, 2011 March 22, :1368 Obesity, Overweight, and LV Diastolic Function eters, less load-dependent than transmitral Doppler flow (26) , allowed us to detect diastolic abnormalities in 183 subjects (19.6% of the study sample) who would otherwise have been classified as normal by Doppler flow analysis alone. Furthermore, the use of E/E= ratio, a widely used indicator of LV filling pressure (25) and an independent predictor of cardiac events including heart failure and myocardial infarction (27) , revealed higher LV filling pressures in obese and overweight patients than in normal weight subjects. Cardiovascular risk factors were significantly more prevalent among overweight and obese persons than among normal weight persons. It is established that hypertension, diabetes, and increased LV mass negatively affect LV diastolic function (16, 17) . However, BMI was still associated with LV diastolic function parameters after controlling for hypertension and diabetes. A subanalysis performed on subjects without hypertension and diabetes further confirmed these findings. Moreover, the increased LV mass that we observed in overweight/obese patients was not just the result of the greater prevalence of cardiovascular risk factors in these subgroups. In fact, BMI was the main predictor of LV mass, independent of the presence of hypertension and diabetes. Although the increased LV mass might be a contributor to the impairment of diastolic function observed in the overweight and obese groups, the relationship between BMI and diastolic function parameters was only slightly weakened by the adjustment for LV mass and other covariates, suggesting that different mechanisms may link the increase in BMI with the impairment in LV diastolic properties. In fact, there is ample evidence that the accumulation of adipose tissue may determine cardiovascular alterations in several metabolic and neurohormonal pathways, causing abnormalities in sodium handling, neuroendocrine activation, the renin-angiotensin-aldosterone system, and increasing myocardial oxidative stress (28, 29) . Changes in myocardial metabolism have been demonstrated in obese patients, with a shift toward free fatty acid utilization and subsequent cardiac lipotoxicity, resulting in cardiomyocyte apoptosis and reduced cardiac efficiency (30, 31) . In particular, myocardial fatty infiltration in obese patients may affect the cardiac structure and function, leading to the development of severe diastolic dysfunction (32, 33) . This is the first large-scale study to evaluate the relation between increased body weight and LV diastolic function, in a randomly selected, elderly cohort, and to account for many factors that would have potentially affected diastolic function. In particular, we are the first to demonstrate that an impairment of diastolic function may already be present in overweight persons. Previous reports had shown a relationship between obesity and diastolic function in extremely selected samples of young women (34 -36) , in subjects without cardiovascular risk factors (37), or in extremely obese subjects (38, 39) . In a large study involving patients who underwent diagnostic coronary angiography, LV enddiastolic pressure was significantly higher in obese patients than in patients with a BMI Ͻ25 kg/m 2 (40) . Surprisingly, in that study, no adjustment was performed for associated risk factors and comorbidities affecting diastolic function. Another study reported that waist circumference, but not BMI, was correlated to lower ventricular filling (41) , which is in agreement with our findings. That study, however, did not perform TDI evaluation, which in our study allowed us to reveal a correlation between BMI and LV filling pressure. Study limitations. Our evaluation of LV diastolic function by Doppler flow analysis did not include parameters such as isovolumic relaxation time, mitral valve deceleration time, or pulmonary venous flow. However, those parameters suffer from high load dependence, and the use of tissue Doppler parameters allowed us to detect diastolic abnormalities even when a pseudonormalized flow pattern was present. The mean age of the study cohort was high, and so was the prevalence of Diastolic Function Parameters by BMI Categories 
Conclusions
LV diastolic dysfunction may be one of the pathophysiological links between overweight/obesity and the associated risk of having heart failure (4). Whereas in the past attention was paid essentially to obesity, our study demonstrates that subclinical signs of LV diastolic function impairment are present in overweight subjects too, and that these abnormalities are independent of associated risk factors. Therapeutic strategies aimed at promoting optimal body weight resulted in improvements in LV systolic and diastolic function (42, 43) , and might have a beneficial effect in preventing or delaying the future development of heart failure, a hypothesis that deserves further investigation.
